DK0689440T3 - Anvendelse af triazinforbindelser som anxiolytikum - Google Patents

Anvendelse af triazinforbindelser som anxiolytikum

Info

Publication number
DK0689440T3
DK0689440T3 DK94909264T DK94909264T DK0689440T3 DK 0689440 T3 DK0689440 T3 DK 0689440T3 DK 94909264 T DK94909264 T DK 94909264T DK 94909264 T DK94909264 T DK 94909264T DK 0689440 T3 DK0689440 T3 DK 0689440T3
Authority
DK
Denmark
Prior art keywords
anxiolytic
triazine compounds
triazine
compounds
Prior art date
Application number
DK94909264T
Other languages
Danish (da)
English (en)
Inventor
Martyn Alan Edwin Critchley
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Application granted granted Critical
Publication of DK0689440T3 publication Critical patent/DK0689440T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK94909264T 1993-03-19 1994-03-18 Anvendelse af triazinforbindelser som anxiolytikum DK0689440T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB939305692A GB9305692D0 (en) 1993-03-19 1993-03-19 Therapeutic triazine compounds and use
PCT/GB1994/000560 WO1994021261A1 (en) 1993-03-19 1994-03-18 Use of triazine compounds as anxiolytics

Publications (1)

Publication Number Publication Date
DK0689440T3 true DK0689440T3 (da) 2000-10-30

Family

ID=10732357

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94909264T DK0689440T3 (da) 1993-03-19 1994-03-18 Anvendelse af triazinforbindelser som anxiolytikum

Country Status (17)

Country Link
US (1) US5658905A (de)
EP (1) EP0689440B1 (de)
JP (1) JP3633618B2 (de)
AP (1) AP464A (de)
AT (1) ATE193446T1 (de)
AU (1) AU6217794A (de)
CY (1) CY2248B1 (de)
DE (1) DE69424779T2 (de)
DK (1) DK0689440T3 (de)
ES (1) ES2147232T3 (de)
GB (1) GB9305692D0 (de)
GR (1) GR3033941T3 (de)
IL (1) IL109035A0 (de)
PH (1) PH31255A (de)
PT (1) PT689440E (de)
WO (1) WO1994021261A1 (de)
ZA (1) ZA941939B (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9424766D0 (en) * 1994-12-07 1995-02-08 Wellcome Found Pharmaceutical composition
GB9726987D0 (en) 1997-12-22 1998-02-18 Glaxo Group Ltd Compounds
WO2009093774A1 (en) * 2008-01-23 2009-07-30 Korea Institute Of Science And Technology Method for treatment of anxiety disorder by regulating t-type calcium channel
US12605388B2 (en) 2024-09-25 2026-04-21 Azurity Pharmaceuticals Ireland Limited Lamotrigine salts, co-crystals, and compositions

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK153787C (da) * 1979-06-01 1989-01-16 Wellcome Found Analogifremgangsmaade til fremstilling af substituerede 3,5-diamino-6-phenyl-1,2,4-triaziner og alfa-cyanobenzyliden-aminoguanidinforbindelser til anvendelse som mellemprodukter herved
DE4118740A1 (de) * 1991-06-05 1992-12-10 Schering Ag Neue kombinationspraeparate zur behandlung des morbus parkinson

Also Published As

Publication number Publication date
CY2248B1 (en) 2003-07-04
GR3033941T3 (en) 2000-11-30
EP0689440B1 (de) 2000-05-31
IL109035A0 (en) 1994-06-24
WO1994021261A1 (en) 1994-09-29
US5658905A (en) 1997-08-19
DE69424779T2 (de) 2000-11-02
DE69424779D1 (de) 2000-07-06
AP9400628A0 (en) 1994-04-30
ATE193446T1 (de) 2000-06-15
JP3633618B2 (ja) 2005-03-30
GB9305692D0 (en) 1993-05-05
EP0689440A1 (de) 1996-01-03
AP464A (en) 1996-02-20
ZA941939B (en) 1995-09-18
JPH08507783A (ja) 1996-08-20
PT689440E (pt) 2000-10-31
PH31255A (en) 1998-06-18
ES2147232T3 (es) 2000-09-01
AU6217794A (en) 1994-10-11

Similar Documents

Publication Publication Date Title
DK1174431T3 (da) 2-phenyl-substitueret imidazo triazinon som phoshodiesterase-inhibitorer
FI20070002L (fi) Pyridinyylimetyylisulfinyyli-1H-bentsimidatsoliyhdisteiden optisesti puhtaat suolat
DK187691A (da) Fremgangsmaade til nyttiggoerelse af affaldsgods
NO992524D0 (no) Konsenserte bicykliske pyrimidin-derivater
NO943140D0 (no) Heterobicykliske forbindelser
DK0788496T3 (da) Inhibitorer for syntese af apolipoprotein-B
DK0925285T3 (da) Fremgangsmåde til fremstilling af pyrimidinforbindelser
DK0746979T3 (da) Anvendelse af pyrrolforbindelser som antibegroningsmidler
NO970652L (no) Triazin-inneholdende anioniske forbindelser egnet som antivirale forbindelser
EE9400420A (et) Indenoindoolühendite kasutamine
DK0391171T3 (da) Anvendelse af di-styryl-phenyl-triglycolether som krystallisationsinhibitor
DK0696194T3 (da) Anvendelse af indolderivater som 5HT1-antagonister
DK0570136T3 (da) Selektiv overfladeafaluminering af zeolitter
DK0689440T3 (da) Anvendelse af triazinforbindelser som anxiolytikum
DE59407556D1 (de) Neuartiges anxiolytikum
DK0689577T3 (da) Anvendelse af ferroncen
FI961680A7 (fi) Menetelmä epäsymmetrisesti substituoitujen triatsiinien valmistamiseksi
IT9019840A0 (it) Composti triazinici
DK6993D0 (da) Fremgangsmaade til fremstilling af jernholdige oploesninger
FI943119A0 (fi) Heterosyklisellä renkaalla substituoituja bentsyyliamiinijohdannaisia retrovirusvastaisina yhdisteinä
DK0834536T3 (da) Omdannelse af xanthophyller
DK0882722T3 (da) Fremstilling af alpha-tocopherol
FI962010A0 (fi) Immuunivastetta heikentävinä aineina käytettäviä 6-okso-nukleosideja
DK0929525T3 (da) Heteroaryloxyethylaminer som ligander af 5-HT1A-receptor
DK18593D0 (da) Spaendboesning af ekspansionstypen